Shares of Covalon Technologies Ltd. (CVE:COV – Get Free Report) dropped 2.7% during mid-day trading on Monday. The company traded as low as C$3.90 and last traded at C$3.92. Approximately 15,523 shares traded hands during trading, a decline of 6% from the average daily volume of 16,434 shares. The stock had previously closed at C$4.03.
Covalon Technologies Stock Performance
The company has a debt-to-equity ratio of 5.35, a current ratio of 8.56 and a quick ratio of 6.45. The stock has a 50-day simple moving average of C$3.41 and a 200 day simple moving average of C$2.55. The company has a market capitalization of C$119.31 million, a PE ratio of 27.00 and a beta of 0.94.
About Covalon Technologies
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Further Reading
- Five stocks we like better than Covalon Technologies
- Salesforce Fuels AI Engine With $5.66B Braze Buyout
- ServiceNow Orchestrates AI’s Next Act—Can Earnings Deliver?
- Drone Stocks Have Burned Investors—Are These 4 Different?
- 3M’s Legal Troubles Are Fading. Is the Best Part of Its Rally Still Ahead?
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
